We have developed a new method to detect Parkinson's disease, which only needs body fluids of patients.

Our mission has two key goals:

Enhancing Diagnostic Pathways: We aim to deliver meaningful benefits to patients by improving how Parkinson's Disease is diagnosed. Today, diagnosis relies heavily on clinical evaluations, which can be time-consuming for clinicians and inconsistent due to day-to-day variations. This often leads to delays in reaching a definitive diagnosis.

Supporting Therapeutic Development: We strive to accelerate advancements in drug development and disease management by offering precise monitoring tools. With accurate measurements, we aim to improve patient care and outcomes by enabling better treatments and prognosis.